News
Oral IL-23 receptor antagonist for psoriasis promising: Phase 2b study
Similar to the primary outcome of PASI 75, all treatment groups demonstrated a statistically significant dose-response in PASI 90, compared with...
News
JAK inhibitors efficacious for atopic dermatitis in Asian patients, study finds
The Singapore study is one of the few that have examined the safety and efficacy of JAK inhibitors for treatment of AD in a non-White population...
News
Study finds subcutaneous spesolimab reduces flares in patients with GPP
The intravenous formulation of spesolimab was approved for the treatment of GPP flares in adults by the Food and Drug Administration in September...